Merck (MRK) EBITDA Margin (2009 - 2026)
Merck (MRK) reported EBITDA Margin of 47.46% for Q1 2026, down 6345.0% year-over-year from 0.76% in Q1 2025, and down 265.23% on a QoQ basis from 12.99% in Q4 2025.
Merck (MRK) has 18 years of EBITDA Margin data on file, last reported at 47.46% in Q1 2026.
- Quarterly EBITDA Margin fell 6345.0% year-over-year to 47.46% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 8.41% (down 1638.0% YoY) and the FY2025 annual result came in at 7.21%, down 19.0% from the prior year.
- EBITDA Margin retreated to 47.46% in Q1 2026 per MRK's latest filing, from 12.99% in the prior quarter.
- Across five years, EBITDA Margin topped out at 16.73% in Q3 2025 and bottomed at 62.25% in Q2 2023.
- The 5-year median for EBITDA Margin is 0.06% (2024), against an average of 5.39%.
- The widest annual swing landed in 2023, when EBITDA Margin slumped 6411 bps; it then soared 7628 bps in 2024.
- Tracing MRK's EBITDA Margin over 5 years: stood at 2.66% in 2022, then slumped by 1430 bps to 40.72% in 2023, then jumped by 105 bps to 2.19% in 2024, then slumped by 694 bps to 12.99% in 2025, then tumbled by 265 bps to 47.46% in 2026.
- Per Business Quant, the three latest MRK EBITDA Margin figures stand at 47.46% (Q1 2026), 12.99% (Q4 2025), and 16.73% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 47.98% |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 26.44% |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | 26.60% |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | -47.46% |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 30.94% |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 37.16% |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | -286.83% |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 24.65% |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -47.46% |
| Dec 31, 2025 | -12.99% |
| Sep 30, 2025 | 16.73% |
| Jun 30, 2025 | 9.12% |
| Mar 31, 2025 | 16.00% |
| Dec 31, 2024 | 2.19% |
| Sep 30, 2024 | 0.06% |
| Jun 30, 2024 | 14.03% |
| Mar 31, 2024 | 13.50% |
| Dec 31, 2023 | -40.72% |
| Sep 30, 2023 | 8.50% |
| Jun 30, 2023 | -62.25% |
| Mar 31, 2023 | -1.91% |
| Dec 31, 2022 | -2.66% |
| Sep 30, 2022 | -2.35% |
| Jun 30, 2022 | 1.86% |
| Mar 31, 2022 | -3.26% |
| Dec 31, 2021 | 0.26% |
| Sep 30, 2021 | 13.81% |
| Jun 30, 2021 | -12.16% |
| Mar 31, 2021 | -1.99% |
| Dec 31, 2020 | -69.18% |
| Sep 30, 2020 | -2.81% |
| Jun 30, 2020 | -0.06% |
| Mar 31, 2020 | 4.36% |
| Dec 31, 2019 | -74.11% |
| Sep 30, 2019 | -13.25% |
| Jun 30, 2019 | -1.21% |
| Mar 31, 2019 | 0.14% |
| Dec 31, 2018 | -6.23% |
| Sep 30, 2018 | -8.84% |
| Jun 30, 2018 | -12.72% |
| Mar 31, 2018 | -18.32% |
| Dec 31, 2017 | -14.96% |
| Sep 30, 2017 | -30.09% |
| Jun 30, 2017 | -6.82% |
| Mar 31, 2017 | -11.09% |
| Dec 31, 2016 | -47.72% |
| Sep 30, 2016 | -4.95% |
| Jun 30, 2016 | -21.07% |
| Mar 31, 2016 | -20.92% |
| Dec 31, 2015 | -29.70% |
| Sep 30, 2015 | -13.54% |
| Jun 30, 2015 | -30.12% |
| Mar 31, 2015 | -23.21% |
| Dec 31, 2014 | 76.91% |
| Sep 30, 2014 | -25.89% |
| Jun 30, 2014 | -27.46% |
| Mar 31, 2014 | -17.65% |
| Dec 31, 2013 | -29.88% |
| Sep 30, 2013 | -23.38% |
| Jun 30, 2013 | -27.60% |
| Mar 31, 2013 | -22.58% |
| Dec 31, 2012 | -24.08% |
| Sep 30, 2012 | -16.70% |
| Jun 30, 2012 | -11.63% |
| Mar 31, 2012 | -13.04% |
| Dec 31, 2011 | -21.11% |
| Sep 30, 2011 | -16.64% |
| Jun 30, 2011 | -21.50% |
| Mar 31, 2011 | -20.12% |
| Dec 31, 2010 | -42.51% |
| Sep 30, 2010 | -33.20% |
| Jun 30, 2010 | -29.16% |
| Mar 31, 2010 | 5.65% |
| Dec 31, 2009 | -17.08% |
| Sep 30, 2009 | 26.41% |
| Jun 30, 2009 | 23.45% |
| Mar 31, 2009 | 20.98% |